H-HCIRNKSVI-OH

Ref. 3D-PP47289

Product Information

• Name: H-HCIRNKSVI-OH

Description

Peptide H-HCIRNKSVI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HCIRNKSVI-OH include the following: NF-κB ACTIVATION FACILITATES PROSTATE CANCER PROGRESSION V Yutkin, S Tayeb, E Pikarsky - The Journal of Urology, 2009 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2809%2960531-0 Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses T Maurer, C Pournaras, JA Aguilar-Pimentel - Oncology: Seminars and , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1078143911003061 Immunostimulatory Cpg-DNA and Psa-peptide vaccination elicits profound cytotoxic T cell responses T Maurer, AJ Aguilar-Pimentel, C Pournaras - The Journal of , 2009 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2809%2960533-4 Global histone modifications as a prognostic marker for biochemical recurrence in patients undergoing radical prostatectomy PJ Bastian, J von der Gathen, P Kahl - The Journal of , 2009 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2809%2960534-6 Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9-and MyD88-deficient mice M Pavlenko , C Leder, S Moreno, V Levitsky, P Pisa - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X07006949 Identification of an immunodominant H-2Db-restricted CTL epitope of human PSA M Pavlenko , C Leder, AK Roos, V Levitsky - The Prostate, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pros.20221 INHIBITION OF THE AQUAPORIN WATER CHANNELS INCREASES THE SENSITIVITY OF PROSTATE CANCER CELLS TO FREEZING INJURY M Ismail, R Morgan, J Davies, H Pandha - The Journal of Urology, 2009 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2809%2960532-2 Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection EN Klyushnenkova, DV Kouiavskaia - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/3/1242/83638 A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer EN Klyushnenkova, DV Kouiavskaia - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2012/06000/A_Cytomegalovirus_based_Vaccine_Expressing_a.4.aspx Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses A Vardeu, C Davis, I McDonald - for Immunotherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639133/

• Brand: Biosynth